Andrew Miller
2021 - Karuna Therapeutics
In 2021, Andrew Miller earned a total compensation of $5.7M as Chief Operating Officer at Karuna Therapeutics, a 23% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $320,850 |
|---|---|
| Option Awards | $4,932,618 |
| Salary | $460,000 |
| Other | $8,700 |
| Total | $5,722,168 |
Miller received $4.9M in option awards, accounting for 86% of the total pay in 2021.
Miller also received $320.9K in non-equity incentive plan, $460K in salary and $8.7K in other compensation.
Rankings
In 2021, Andrew Miller's compensation ranked 2,221st out of 12,415 executives tracked by ExecPay. In other words, Miller earned more than 82.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,221 out of 12,415 | 82nd |
Division Manufacturing | 868 out of 5,508 | 84th |
Major group Chemicals And Allied Products | 331 out of 2,378 | 86th |
Industry group Drugs | 286 out of 2,099 | 86th |
Industry Pharmaceutical Preparations | 184 out of 1,549 | 88th |
Source: SEC filing on April 27, 2022.
Miller's colleagues
We found four more compensation records of executives who worked with Andrew Miller at Karuna Therapeutics in 2021.
News
Karuna Therapeutics CEO Steven Paul's 2021 pay jumps 48% to $13M
April 27, 2022
Karuna Therapeutics CEO Steven Paul's 2020 pay slips 11% to $8.9M
April 27, 2021
Karuna Therapeutics CEO Steven Paul's 2019 pay jumps 932% to $10M
April 29, 2020
PTC CEO James Heppelmann's 2018 pay jumps 357% to $50M
January 23, 2019